Depression: A long-term illness and its treatment

International Clinical Psychopharmacology

Volumn 13, Issue SUPPL. 6, 1998, Pages

  Montgomery, S A ^a   Kasper, S ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Depression; Fluvoxamine; Long term; Prophylaxis; Recurrence; Relapse; Selective serotonin reuptake inhibitors

Indexed keywords

FLUVOXAMINE; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DEPRESSION; DISABILITY; DRUG TOLERABILITY; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENCE RISK; RELAPSE;

EID: 0031853245     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199807006-00005     Document Type: Article

References (18)

1. Angst J (1992). How recurrent and predictable is depressive illness? In: Long-Term Treatment of Depression (Montgomery, SA, Rouillon F, eds), Chichester: Wiley. pp. 1-14.
2. Coppen A, Ghose K, Montgomery SA, Rama Rao VA, Bailey J, Jorgensen A (1978). Continuation therapy with amitriptyline in depression. Br J Psychiatry 133:28-33.
3. Donoghue JM, Tylee A (1996). The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 168:164-168.
4. Frank E, Kupfer DJ, Perel JM, Comes C, Jarrett DB, Mallinger AG, et al. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099.
5. Frank E, Kupfer DJ, Perel JM, Comes C, Mallinger AG, Thase ME, et al. (1993). Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 27:139-145.
6. Georgotas A, McCue RE, Cooper TB (1989). A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 46:783-786.
7. Hirschfeld RMA (1994). Long-term management of depression. Am J Psychiatry 97 (suppl. 6A):33-38.
8. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A (1982). Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar illness. Arch Gen Psychiatry 39:1065-1069.
9. Kupfer DJ, Frank E, Perel JM, Comes C, Mallinger AG, Thase ME, et al. (1992). Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49:769-773.
10. Lépine J-P, Gastpar M, Mendlewicz J, Tylee A, on behalf of the DEPRES Steering Committee (1997). Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 12:19-29.
11. Mindham RHS, Howland C, Shepherd M (1973). An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 3:5-17.
12. Montgomery SA, Doogan DP, Burnside R (1991). The influence of different relapse criteria on the assessment of long-term efficacy of sertraline. Int Clin Psychopharmacol 6 (suppl. 2):37-46.
13. Montgomery SA, Dunbar GC (1993). Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 8:189-195.
14. Montgomery SA, Rasmussen JGC, Tanghoj P (1993). A 24 week study of 20 mg citalopram, 40 mg citalopram and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 8:181-188.
15. Prien RF, Klett CJ, Caffey EM (1973). Lithium carbonate and imipramine in the prevention of affective episodes. Arch Gen Psychiatry 29:420-425.
16. Prien RF, Kupfer DJ, Manskey PA, Small JG, Tuasou VB, Voss C, Johnson WE (1984). Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine and a lithium carbonate-imipramine carbonate combination. Arch Gen Psychiatry 41:1096-1104.
17. Rosenbaum JF, Quitkin FM, Fava M, Amsterdam JD, Fawcett J, Zajecka J, et al. (1993). Fluoxetine vs. placebo: long-term treatment of MDD. XXXII Annual Meeting of the American College of Neuropsychopharmacology. Hawai, December [abstract].
18. Terra J-L, Montgomery SA (1998). Fluvoxamine prevents recurrence of depression: Results of a long-term, double-blind, placebo-controlled study. Int Clin Psychopharmacol 13:55-62.